ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Tribunal upholds CMA’s decision to fine Lexon ￡1.2m pharmatimes
March 02, 2021The Competition Appeal Tribunal (CAT) has maintained a decision made last year by the UK’s Competition and Markets Authority (CMA) to fine pharmaceutical firm Lexon ￡1.2m after finding the company guilty of breaking competition law.
Pharma Sources Insight January 2025
